Evaluation of Mycobacterium bovis double knockout mce2-phoP as candidate vaccine against bovine tuberculosis

Tuberculosis

Volumn 95, Issue 2, 2015, Pages 186-189

  García, Elizabeth ^a   Bianco, María V ^a   Gravisaco, María José ^a   Rocha, Rosana V ^a   Blanco, Federico C ^a   Bigi, Fabiana ^a  

^a CICVyA   (Argentina)

Author keywords

Bovine tuberculosis; Mycobacerium bovis; phoP; Vaccine

Indexed keywords

BCG VACCINE; MCE2 PHOP VACCINE; PHOP PROTEIN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CYTOKINE; LIVE VACCINE; MCE2 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; PHOP PROTEIN, BACTERIA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOVINE TUBERCULOSIS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG SCREENING; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; VACCINATION; VIRULENCE; WILD TYPE; ANIMAL; BACTERIAL COUNT; BAGG ALBINO MOUSE; BIOSYNTHESIS; BOVINE; DISEASE MODEL; EVALUATION STUDY; GENE INACTIVATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; NUDE MOUSE; PATHOGENICITY; TH1 CELL; TUBERCULOSIS, BOVINE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CATTLE; COLONY COUNT, MICROBIAL; CYTOKINES; DISEASE MODELS, ANIMAL; GENE KNOCKOUT TECHNIQUES; MICE, INBRED BALB C; MICE, NUDE; MYCOBACTERIUM BOVIS; TH1 CELLS; TUBERCULOSIS VACCINES; TUBERCULOSIS, BOVINE; VACCINES, ATTENUATED; VIRULENCE;

EID: 84924937072     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2015.01.001     Document Type: Article

References (13)

1. A. Arbues, J.I. Aguilo, J. Gonzalo-Asensio, D. Marinova, S. Uranga, E. Puentes, and C. Martin Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials Vaccine 31 2013 4867 4873 10.1016/j.vaccine.2013.07.051
2. F.C. Blanco, M.V. Bianco, S. Garbaccio, V. Meikle, M.J. Gravisaco, V. Montenegro, and A. Cataldi Mycobacterium bovis Δmce2 double deletion mutant protects cattle against challenge with virulent M. bovis Tuberculosis (Edinburgh, Scotland) 93 3 2013 363 372 10.1016/j.tube.2013.02.004
3. F.C. Blanco, M. Soria, M.J. Gravisaco, M.V. Bianco, V. Meikle, S. Garbaccio, and F. Bigi Assessment of the immune responses induced in cattle after inoculation of a Mycobacterium bovis strain deleted in two mce2 genes J Biomed Biotechnol 2012 2012 258353 10.1155/2012/258353
4. B.M. Buddle, F.E. Aldwell, G.W. De Lisle, H.M. Vordermeier, R.G. Hewinson, and D.N. Wedlock Low oral BCG doses fail to protect cattle against an experimental challenge with Mycobacterium bovis Tuberc Edinb Scotl 91 2011 400 405
5. M.A. Forrellad, L.I. Klepp, A. Gioffré, García, J. Sabio Y, H.R. Morbidoni, M. de la P. Santangelo, and F. Bigi Virulence factors of the Mycobacterium tuberculosis complex Virulence 4 1 2013
6. J. Gonzalo-Asensio, W. Malaga, A. Pawlik, C. Astarie-Dequeker, C. Passemar, F. Moreau, and C. Guilhot Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator Proc Natl Acad Sci U. S. A 111 2014 11491 11496 10.1073/pnas.1406693111
7. A.T. Kamath, U. Fruth, M.J. Brennan, R. Dobbelaer, P. Hubrechts, M.M. Ho, and P.-H. Lambert New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development Vaccine 23 29 2005 3753 3761 10.1016/j.vaccine.2005.03.001
8. C. Martin, A. Williams, R. Hernandez-Pando, P.J. Cardona, E. Gormley, and Y. Bordat B. Gicquel The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs Vaccine 24 2006 3408 3419 10.1016/j.vaccine.2006.03.017
9. M.D.L.P. Santangelo, P.M. Gest, M.E. Guerin, M. Coinçon, H. Pham, and G. Ryan M. Jackson Glycolytic and non-glycolytic functions of Mycobacterium tuberculosis fructose-1,6-bisphosphate aldolase, an essential enzyme produced by replicating and non-replicating bacilli J Biol Chem 286 2011 40219 40231 10.1074/jbc.M111.259440
10. L. Solans, J. Gonzalo-Asensio, C. Sala, A. Benjak, S. Uplekar, and J. Rougemont S.T. Cole The PhoP-Dependent ncRNA Mcr7 modulates the TAT secretion system in Mycobacterium tuberculosis PLoS Pathog 10 2014 10.1371/journal.ppat.1004183
11. D. Van Soolingen, P.W. Hermans, P.E. de Haas, D.R. Soll, and J.D. van Embden Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis J Clin Microbiol 29 11 1991 2578 2586 Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=270376&tool=pmcentrez&rendertype=abstract
12. K.B. Walker, M.J. Brennan, M.M. Ho, J. Eskola, G. Thiry, and J. Sadoff P.H. Lambert The second geneva consensus: recommendations for novel live TB vaccines Vaccine 28 11 2010 2259 2270 10.1016/j.vaccine.2009.12.083
13. W.R. Waters, M.V. Palmer, B.M. Buddle, and H.M. Vordermeier Bovine tuberculosis vaccine research: historical perspectives and recent advances Vaccine 30 16 2012 2611 2622 10.1016/j.vaccine.2012.02.018